Tradestie Institutional Equity Comparison Engine
SYK vs BSX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SYK Overall Edge
SYK Captures Institutional Edge (3โ1 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Stryker Corporation (SYK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while BSX counters with relative strength in Valuation. Fundamentally, SYK trades at 19.0x Forward P/E with 24.0% operating margin (+7.6% YoY revenue) versus BSX at 14.2x Forward P/E and 19.6% operating margin (+1.4% YoY). In options structure, SYK sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro) against BSX sits in CONSOLIDATION (53rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
BSX
SYK 19.0x vs BSX 14.2x Fwd P/E
Growth & Margin Winner
SYK
Op Margin 24.0% vs 19.6% ยท YoY +7.6% vs +1.4%
Momentum & Technical Winner
SYK
1Y -16.8% vs -58.3% ยท 52W Pos 36% vs 6%
Options & Structure Winner
SYK
SURGE (5th %ile IV) vs CONSOLIDATION (53rd %ile IV)
SYK
NYSE
Stryker Corporation
Surgical & Medical Instruments & Apparatus
$310.79
+0.37% 1D
Market Cap
$118.9B
1M Return
+5.47%
1Y Return
-16.77%
Forward P/E
19.0x
Unified AI Score
46.5 / 100
HOLD
Tech 37.0
Fund 49.0
Flow 58.0
Mom 60.0
BSX
NYSE
Boston Scientific Corp.
Surgical & Medical Instruments & Apparatus
$43.74
-1.35% 1D
Market Cap
$64.1B
1M Return
-1.46%
1Y Return
-58.33%
Forward P/E
14.2x
Unified AI Score
58.8 / 100
HOLD
Tech 49.0
Fund 58.0
Flow 68.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SYK -16.77%
BSX -58.33%
Spread: +41.56 pp (SYK Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SYK Revenue | BSX Revenue | SYK Op. Margin | BSX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $13.6B | $9.82B | 18.7% | 15.3% | SYK |
| FY2019 | $14.9B | $10.7B | 18.2% | 14.1% | SYK |
| FY2020 | $14.3B | $9.91B | 15.5% | -0.8% | SYK |
| FY2021 | $17.1B | $11.9B | 15.1% | 10.1% | SYK |
| FY2022 | $18.4B | $12.7B | 15.4% | 13.0% | SYK |
| FY2023 | $20.5B | $14.2B | 19.0% | 16.5% | SYK |
| FY2024 | $22.6B | $16.8B | 16.3% | 15.5% | SYK |
| FY2025 | $25.1B | $20.1B | 19.5% | 18.0% | SYK |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SYK | BSX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $118.9B | $64.1B | Larger Scale | SYK |
| Trailing P/E Ratio Valuation | 33.3x | 18.6x | Lower Multiple | BSX |
| Forward P/E Ratio Valuation | 19.0x | 14.2x | Lower Multiple | BSX |
| Revenue Growth (YoY) Growth | +7.6% | +1.4% | Higher Growth | SYK |
| Operating Margin (TTM) Profitability | 24.0% | 19.6% | Higher Margin | SYK |
| Net Profit Margin Profitability | 13.8% | 16.6% | Higher Margin | BSX |
| Return on Equity (ROE) Capital Efficiency | 16.0% | 14.1% | Higher ROE | SYK |
| 52-Week Range Position Momentum | 36% ($267โ$389) | 6% ($40โ$106) | Stronger Trend | SYK |
| Beta / 30D Volatility Risk Regime | 0.22ฮฒ ยท 50% Vol | 0.32ฮฒ ยท 45% Vol | Lower Realized Risk | BSX |
| Unified Institutional Score Composite Signal | 46.5 / 100 (HOLD) | 58.8 / 100 (HOLD) | Higher Composite | BSX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SYK vs BSX Buy Guide
SYK
SURGE
8d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
5th %ile
IV Regime
Compressed (<25th %ile)
BSX
CONSOLIDATION
62d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
53rd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SYK nor BSX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.